Proteomic phenotyping: Metastatic and invasive breast cancer

Cancer Letters

Volumn 210, Issue 2, 2004, Pages 245-253

  Hathout, Yetrib ^a,b   Gehrmann, Marion L ^a   Chertov, Andrei ^a   Fenselau, Catherine ^a  

^a Bldg 142   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Adriamycin; Breast cancer cell lines; MCF 7 ADR; Metastasis; Proteome phenotyping

Indexed keywords

DOXORUBICIN;

ARTICLE; BREAST CANCER; BREAST DUCT; CANCER CELL CULTURE; CANCER INFILTRATION; CANCER INVASION; CARCINOMA CELL; CELL POPULATION; CELL STRAIN MCF 7; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; LABORATORY; MASS SPECTROMETRY; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST NEOPLASMS; CARCINOMA, DUCTAL; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PHENOTYPE; PROTEOMICS; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 2942585115     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.01.019     Document Type: Article

References (33)

1. Soule H.D., Vazquez J., Long A., Albert S., Brennan M. A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51:1973;1409-1416
2. Brooks S.C., Locke E.R., Soule H.D. Estrogen receptor in human cell line (MCF-7) from breast carcinoma. J. Biol. Chem. 248:1973;6251-6253
3. Batist G., Tulpule A., Sinha B.K., Katki A.G., Myers C.E., Cowan K.H. Overexpression of novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J. Biol. Chem. 261:1986;15544-15549
4. Schneider E., Horton J.K., Yang C.-H., Nakagawa M., Cowan K.H. Multidrug resistance-associated protein gene over expression and reduced drug sensitivity of topoisomerase II in human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res. 54:1994;152-158
5. Nakagawa M., Schneider E., Dixon K.H., Horton J., Kelley K., Morrow C., Cowan K.H. Reduced intracellular drug accumulation in the absence of P-glycoprotein (mdr1) over expression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res. 52:1992;6175-6181
6. Moscow J.A., Swanson C.A., Cowan K.H. Decreased melphalan accumulation in human breast cancer cell line selected fro resistance to melphalan. Br. J. Cancer. 68:1993;732-737
7. Scudiero D.A., Monks A., Sausville V.A. Cell line in the NCI anticancer screen [Letter]. J. Natl. Cancer Inst. 90:1998;862
8. Pirinia F., Breuleux M., Schneider E., Hochmeister M., Bates S.E., Marti A., et al. Uncretain identity of doxorubicin-resistant MCF-7 cell lines expressing mutated p53. J. Natl. Cancer Inst. 92:2000;1535-1536
9. Mehta K., Devarajan E., Chen J., Multani A., Pthak S. Multidrug-resistant MCF-7 cells: an identity crisis. J. Natl. Cancer Inst. 94:2002;1652-1653
10. Ross D.T., Scherf U., Eisen M.B., Perou C.M., Rees C., Spellman P., et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24:2000;227-235
11. Devarajan E., Chen J., Multani A.S., Ptahak S., Sahin A.A., Mehta K. Human breast cancer MCF-7 cell line contains inherently drug-resistant subclones with distinct genotypic and phenotypic features. Int. J. Oncol. 20:2002;913-920
12. Gehrmann M., Fenselau C., Hathout Y. Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line. J. Proteome Res. 2004;. in press
13. Chen Y.-N., Mickley L.A., Schwartz A.M., Acton E.M., Hwang J., Fojo A.T. Characterization of adriamycin-resistant human breast cancer cells which display overexpression of novel resistance-related membrane protein. J. Biol. Chem. 265:1990;10073-10080
14. Ramsby M.L., Makowski G.L. Differential detergent fractionation of eukaryotic cells. Link A.J. Methods in Molecular Biology. 1999:1999;53-66 Humana Press, Totowa, NJ
15. Jensen O.N., Wilm M., Shevchenko A., Mann M. Sample preparation methods for mass spectrometry peptide mapping directly from 2-DE gels. Link A.J. Methods in Molecular Biology. 1999:1999;513-530 Humana Press, Totowa, NJ
16. Yeh C.C., Ochipinti S.J., Cowan K.H., Chabner B.A., Myers C.E. Adriamycin resistance in human tumor cells associated with marked alterations in the regulation of the hexose monophosphate shunt and its response to oxidant stress. Cancer Res. 47:1987;5994-5999
17. Doyle L.A., Yang W., Abruzzo L.V., Krogrmann T., Gao Y., Rishi A.K., Ross D.D. A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc. Natl. Acad. Sci. USA. 95:1998;15665-15670
18. Cailleau R., Olive M., Cruciger Q.V. Long-term human breast carcinoma cell line of metastatic origin: preliminary characterization. In Vitro. 14:1978;911-915
19. Price J.E., Polyzos A., Zhang R.D., Daniels L.M. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res. 50:1990;717-721
20. Vickers P.J., Dickson R.B., Shoemaker R., Cowan K.H. A multidrug-resistant MCF-7 human breast cancer cell line which exhibits cross-resistance to antiestrogens and hormone-independent tumor growth in vivo. Mol. Endocrinol. 2:1988;886-892
21. Dawling S., Roodi N., Mernaugh R.L., Wang X., Parl F.F. Catechol-omethyltransferase (COMT)-mediated metabolism of catechol-estrogen: comparison of wild-type and variant COMT isoforms. Cancer Res. 61:2001;6716-6722
22. Matsui A., Ikeda T., Enomoto K., Nakashima H., Omae K., Watanabe M., et al. Progression of human breast cancers to the metastatic state is linked to genotypes of catechol-o-methyltransferase. Cancer Lett. 150:2000;23-31
23. Koukourakis M.I., Giatromanolaki A., Sivridios E., Bougioukas G., Didilis V., Gatter K.C., Harris A.L. Lactate dehydrogenase-5 (lDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumor hypoxia, angiogenic factor production and poor prognosis. Br. J. Cancer. 89:2003;877-885
24. Jiang D., Ying W., Lu Y., Wan J., Zhai Y., Liu W., et al. Identification of metastasis-associated proteins by proteomics analysis and functional exploration of interleukin-18 in metastasis. Proteomics. 3:2003;724-737
25. Sgroi D.C., Teng S., Robinson G., LeVangie R., Hudson J.R. Jr., Elkahloun A.G. In vivo gene expression profile analysis of human breast cancer progression. Cancer Res. 59:1999;5656-5661
26. Minafra S., Morello V., Glorioso F., La Fiura A.M., Tomasion R.M., Feo S., et al. A new cell line (8701-BC) from primary ductal infiltrating carcinoma of human breast. Br. J. Cancer. 60:1989;185-192
27. Pucci-Minafra I., Fontana S., Cancemi P., Basirico L., Caricato S., Minafra S.A. Contribution to breast cancer cell proteomics: detection of new sequence. Proteomics. 2:2002;919-927
28. Hibi K., Westra W.H., Borges M., Goodman S., Sidransky D., Jen J. PGP9.5 as a candidate tumor marker for non-small-cell lung cancer. Am. J. Pathol. 155:1999;711-715
29. Brichory F., Beer D., Le Naour F., Giordano T., Hanash S. Proteomics-based identification of protein gene product 9.5 as a tumor antigen that induces a humeral immune response in lung cancer. Cancer Res. 61:2001;7908-7912
30. Tezel E., Hibi K., Nagasaka T., Nakao A. PGP9.5 as prognostic factor in pancreatic cancer. Clin. Cancer Res. 6:2000;4764-4767
31. Yamazaki T., Hibi K., Takase T., Tezel E., Nakayama H., Kasai K., et al. PGP9.5 as a marker for invasive colorectal cancer. Clin. Cancer Res. 8:2002;192-195
32. De Larco J.E., Wuerts B.R., Manivel J.C., Furcht L.T. Progression and enhancement of metastatic potential after exposure of tumor cells to chemotherapeutic agents. Cancer Res. 61:2001;2857-2861
33. Cassanelli S., Luois J., Seigneurin D. Progesterone receptor heterogeneity in MCF-7 cell subclones is related to clonal origin and kinetics data. Tumour Biol. 16:1995;222-229